Kelly Schick
Human Resources Officer chez C4 THERAPEUTICS, INC.
Fortune : 426 891 $ au 31/03/2024
Postes actifs de Kelly Schick
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| C4 THERAPEUTICS, INC. | Human Resources Officer | 12/01/2021 | - |
ScripNet LLC
 ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Corporate Officer/Principal | - | - |
Historique de carrière de Kelly Schick
Anciens postes connus de Kelly Schick
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2011 | - |
| AMAG PHARMACEUTICALS, INC. | Human Resources Officer | 01/09/2016 | - |
Formation de Kelly Schick
| Boston University | Undergraduate Degree |
| The Curtis L. Carlson School of Management | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Human Resources Officer | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Technology Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Technology Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Kelly Schick
- Expérience
